Tag: investment
-
Gene-Editing Enzyme Start-Up Gains $65M
A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round.
-
Coronavirus Antibody Maker Raises $80M in New Funds
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds.
-
Oral Drug Delivery Company Acquired in $1.8B Deal
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk.
-
Diabetes Foundation, Lilly Invest in Protein Biotech
A biotechnology company creating synthetic sensing proteins received equity investments to support work on its variable-release insulin for people with type 1 diabetes.
-
Venture Rounds, IPOs, Mergers Vanish in Election Week
Nationwide jitters in the U.S. appear to be affecting venture capital activities in the week of the presidential and congressional elections.
-
Infographic – Q3 Health Care A.I. Funding Soars
In the third quarter of 2020, worldwide investments in artificial intelligence applications in health care rose to a new high, $2.1 billion.
-
Covid-19 Drug Biotech Raises $300M in IPO
A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock.
-
Novartis Gains Synthetic Protein Therapies for Covid-19
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components.
-
Bayer Gains Gene Therapy Biotech in $4B Deal
Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders.
-
Start-Up Developing Engineered B-Cell Therapies
A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system.